The study, published last year, was found to contain unreliable and “implausible” data.
obesity
Auto Added by WPeMatico
Semaglutide and tirzepatide are among 20 new additions to the WHO’s list of essential medicines.
In new Phase III trial data released Tuesday, people taking orforglipron lost substantially more weight than people...
The Danish pharmaceutical company has struggled in recent months to meet its lofty sales expectations.
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of...
In early animal tests, the experimental TDN triggered weight loss without nausea or vomiting.
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea...
New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience...
People taking Amgen’s MariTide lost up to 20% of their body weight in a Phase II trial.
